Of course, regarding the activity sector of the CureVac Company you should attentively follow the innovations of this group and the clinical trials undertaken relating to its products undergoing development and the results obtained. This data can be found directly on the official company website.
The biotechnological company CureVac owns and operates its own production facilities. In 2020 it employed nearly 150 people on these production sites which included one factory already operational and two under construction. Also, the company will shortly create a fourth factory with the objective of producing billions of vaccine doses per year. To do so the company has received support of around 80 million Euros from the European Union.